<?xml version="1.0" encoding="UTF-8"?>
<ref id="B152-vaccines-08-00036">
 <label>152.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>McGoldrick</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Macadam</surname>
    <given-names>A.J.</given-names>
   </name>
   <name>
    <surname>Dunn</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Rowe</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Burlison</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Minor</surname>
    <given-names>P.D.</given-names>
   </name>
   <name>
    <surname>Meredith</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Evans</surname>
    <given-names>D.J.</given-names>
   </name>
   <name>
    <surname>Almond</surname>
    <given-names>J.W.</given-names>
   </name>
  </person-group>
  <article-title>Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus</article-title>
  <source>J. Virol.</source>
  <year>1995</year>
  <volume>69</volume>
  <fpage>7601</fpage>
  <pub-id pub-id-type="doi">10.1128/JVI.69.12.7601-7605.1995</pub-id>
  <pub-id pub-id-type="pmid">7494267</pub-id>
 </element-citation>
</ref>
